货币 / BIIB
BIIB: Biogen Inc
126.64
USD
1.92
(1.49%)
今日BIIB汇率已更改-1.49%。当日,交易品种以低点125.97和高点129.62进行交易。
关注Biogen Inc动态。实时报价将帮助您快速应对市场变化。通过在不同的时间周期之间切换,您可以按分钟、小时、天、周和月监控汇率趋势和动态。使用这些信息来预测市场变化并做出明智的交易决策。
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
BIIB新闻
- Seeking Alpha Alkermes: A More Than Solid Quarter (NASDAQ:ALKS)
- Investing Apple, Amazon, Kla-tencor set to report earnings Thursday
- Investing Lecanemab real-world study shows promising results in early Alzheimer’s
- Zacks Biogen (BIIB) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
- Investing Biotech stocks dip as Trump administration mulls patent fee overhaul
- Zacks Biogen Gears Up to Report Q2 Earnings: Here's What to Expect
- Zacks BioMarin Pharmaceutical (BMRN) Reports Next Week: Wall Street Expects Earnings Growth
- Zacks Analysts Estimate Biogen Inc. (BIIB) to Report a Decline in Earnings: What to Look Out for
- TipRanks QQQ ETF News, 7/24/2025 - TipRanks.com
- Benzinga Trump Tariffs Forces AstraZeneca To Bring Substantial Pharmaceutical Production To US - AstraZeneca (NASDAQ:AZN)
- Benzinga FDA Names Biotech Veteran George Tidmarsh To Lead Drug Evaluation Division - Sarepta Therapeutics (NASDAQ:SRPT), Biogen (NASDAQ:BIIB)
- Investing BMO Capital reiterates Eli Lilly stock rating with $900 price target
- Zacks How Will AbbVie's Neuroscience Franchise Perform in Q2 Earnings?
- TipRanks QQQ ETF News, 7/22/2025 - TipRanks.com
- Benzinga Biogen Bets Big On $2 Billion Expansion To Boost US Drug Manufacturing - Biogen (NASDAQ:BIIB)
- Seeking Alpha Eli Lilly: Competition Melts Away (NYSE:LLY)
- Investing Truist Securities initiates Biogen stock coverage with Hold rating
- Investing Biogen to invest $2 billion more in North Carolina
- Investing Biogen to invest $2 billion in North Carolina manufacturing expansion
- Investing Harrow Health stock outlook strong as Cantor reiterates Overweight rating
- Investing Ionis Pharma CEO Monia sells $48,416 in stock
- Benzinga Is Bristol-Myers Squibb Still An Undervalued Biopharma Play? - Bristol-Myers Squibb (NYSE:BMY)
- Investing Biogen stock price target raised to $130 from $119 at UBS on Alzheimer’s outlook
- Seeking Alpha Patient Capital Management Q2 2025 Investment Review
日范围
125.97
129.62
年范围
110.03
219.44
- 前一天收盘价
- 127.90
- 开盘价
- 128.56
- 卖价
- 126.64
- 买价
- 126.94
- 最低价
- 125.97
- 最高价
- 129.62
- 交易量
- 4.221 K
- 日变化
- -1.49%
- 月变化
- 1.26%
- 6个月变化
- -11.29%
- 年变化
- -41.23%
30 七月, 星期三
12:15
USD
- 实际值
- 104 K
- 预测值
- 57 K
- 前值
- -33 K
12:30
USD
- 实际值
- 3.0%
- 预测值
- 0.4%
- 前值
- -0.5%
12:30
USD
- 实际值
- 2.0%
- 预测值
- 3.6%
- 前值
- 3.8%
12:30
USD
- 实际值
- 2.5%
- 预测值
- 3.3%
- 前值
- 3.5%
12:30
USD
- 实际值
- 2.1%
- 预测值
- 3.1%
- 前值
- 3.7%
12:30
USD
- 实际值
- 1.4%
- 预测值
- 0.8%
- 前值
- 0.5%
12:30
USD
- 实际值
- 6.3%
- 预测值
- -1.5%
- 前值
- -3.1%
14:00
USD
- 实际值
- -0.8%
- 预测值
- 1.6%
- 前值
- 1.8%
14:00
USD
- 实际值
- -2.8%
- 预测值
- 9.6%
- 前值
- 1.1%
14:00
USD
- 实际值
- 72.0
- 预测值
- 前值
- 72.6
14:30
USD
- 实际值
- 7.698 M
- 预测值
- 0.914 M
- 前值
- -3.169 M
14:30
USD
- 实际值
- 0.690 M
- 预测值
- 0.114 M
- 前值
- 0.455 M
14:30
USD
- 实际值
- 1.317 M
- 预测值
- 0.738 M
- 前值
- -0.740 M
14:30
USD
- 实际值
- 0.130 M
- 预测值
- -0.004 M
- 前值
- 0.095 M
14:30
USD
- 实际值
- 3.635 M
- 预测值
- -0.111 M
- 前值
- 2.931 M
14:30
USD
- 实际值
- 0.676 M
- 预测值
- 0.915 M
- 前值
- 0.282 M
14:30
USD
- 实际值
- 0.739 M
- 预测值
- 0.608 M
- 前值
- 0.003 M
14:30
USD
- 实际值
- -2.724 M
- 预测值
- 0.879 M
- 前值
- -1.738 M
14:30
USD
- 实际值
- -0.025 M
- 预测值
- 前值
- 0.087 M
14:30
USD
- 实际值
- -0.1%
- 预测值
- 前值
- 1.6%
18:00
USD
- 实际值
- 预测值
- 前值
18:00
USD
- 实际值
- 4.50%
- 预测值
- 前值
- 4.50%
18:30
USD
- 实际值
- 预测值
- 前值